FDA warning letters to peptide vendors (2026)

In 2026 the FDA sent formal warning letters to at least 13 online sellers of injectable "research use only" peptides, rejecting their RUO disclaimers as pretextual given how the products were actually marketed — most often for GLP-1-class weight loss. This page is a plain index of those letters, not an independent finding of ours.

The letters

Every row links directly to the letter's own page on fda.gov. Open it — that's the primary source, not our summary of it. Four vendors we separately checked for the Register sell the same kind of RUO injectables but don't appear here because we found no FDA letter addressed to them; a missing FDA letter is not the same as a clean bill of health, just the absence of this specific kind of public record.

What a warning letter is — and isn't

An FDA warning letter is the agency's notice that it believes a company is violating the law, most often here by selling an "unapproved new drug" under section 505(a) of the Food, Drug and Cosmetic Act. The FDA's stated reasoning across this batch: intended use is judged by the whole marketing context under 21 U.S.C. §321(g)(1), not by a disclaimer alone, so pages describing weight loss, appetite suppression or blood-sugar effects make a product a drug regardless of a "research use only" label.

It is not a recall, a criminal conviction, or proof the company has stopped selling. A warning letter typically asks for corrective action within a set window and can be followed by a closeout letter once the FDA is satisfied — none of the 13 above has a published closeout as of this writing, meaning the FDA has not indicated the matter is resolved. It also isn't necessarily the full regulatory picture for a given seller: a seller can be cited under a storefront or dba name distinct from the entity you interact with.

Why this isn't part of the Register

The Register's own findings are anonymous when a product fails: we report the aggregate result, not the brand, because that verdict is our conclusion against a standard we wrote. This page is different in kind, not just in tone — it reports the government's own public enforcement record, already published under each company's name at fda.gov. We're not naming these companies; the FDA already did, publicly, and we're indexing that record rather than duplicating it as our own accusation.

That distinction is also why this list isn't scored, graded, or marked "listed" / "not listed" the way Register entries are — there's no standard being applied here beyond "does a warning letter addressed to this company exist."

If you're using one of these sites

A warning letter on this list doesn't by itself tell you what's actually in a given vial, and its absence for a vendor doesn't mean one is coming or that the vendor is otherwise clean. See vendor red flags for the broader checklist, and are peptides legal? for what "research use only" actually does and doesn't change about your own legal exposure buying from a site like this.